Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Clinical trial NCT05498792 · RECRUITING

Trial details

NCT number: NCT05498792
Sponsor: Fox Chase Cancer Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Melanoma

Start date: 2022-11-30
Primary completion: 2027-03-04
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.